Analysis of risk factors for benign prostate enlargement with prostate calcification

被引:0
作者
Chen, Xiaoling [1 ]
Han, Yanzhi [2 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 5, Canc Ctr, Zhuhai 519000, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 5, Dept Gastroenterol, Zhuhai 519000, Guangdong, Peoples R China
关键词
Benign prostatic enlargement; Prostate calcification; Risk factor analysis; URINARY-TRACT SYMPTOMS; HYPERPLASIA; MANAGEMENT; EPIDEMIOLOGY;
D O I
10.22514/jomh.2024.014
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The occurrence of benign prostatic hyperplasia (BPH) accompanied by calcification can reduce the quality of life and treatment effectiveness of patients. This study focuses on middle-aged and elderly patients in physical examination centers, and divides them into a control group and a study group based on their condition. By comparing the general information and serum indicators of the subjects, descriptive analysis methods are used to analyze the risk factors for prostate hyperplasia accompanied by calcification. Among 700 male physical examinations, there were 305 patients with benign prostate enlargement, with a prevalence rate of 43.57%. There were 290 patients with prostate calcification, accounting for 41.43%. Among them, there were 203 patients with prostate calcification in BPH, accounting for 66.56%. Multivariate logistic regression analysis showed that age, education and culture, diabetes, hypertension, uric acid (UA) and blood urea nitrogen (BUN) are independent risk factors for prostate calcification, while height is the protective factor. The prevalence rate of BPH and BPH with prostate calcification is high in middle-aged and elderly men. Although the cause of calcification is still unclear, age, education, occupation, diabetes, hypertension, UA, BUN and prostatespecific antigen (PSA) indicators are closely related to the disease. Therefore, early intervention should be carried out according to the above risk factors to prevent the occurrence of the disease as soon as possible.
引用
收藏
页码:107 / 113
页数:7
相关论文
共 31 条
[1]   Challenging Case of Holmium Laser Enucleation of the Prostate after Prior Prostatic Focal Laser Ablations and Rezum [J].
Agarwal, Deepak K. ;
Krambeck, Amy E. .
UROLOGY, 2021, 153 :358-358
[2]   Lower urinary tract symptoms in patients with small prostates: Smooth muscle proliferation and calcification might be causative factors [J].
Ather, Muhammad Muneeb ;
Aman, Sadia ;
Qamar, Huma ;
Latif, Rabia ;
Baloch, Muhammad Bahadur ;
Zehra, Uruj .
LUTS-LOWER URINARY TRACT SYMPTOMS, 2022, 14 (04) :267-272
[3]   Exploratory assessment of pineal gland volume, composition, and urinary 6-sulfatoxymelatonin levels on prostate cancer risk [J].
Bazzi, Latifa A. ;
Sigurdardottir, Lara G. ;
Sigurdsson, Sigurdur ;
Valdimarsdottir, Unnur ;
Torfadottir, Johanna ;
Aspelund, Thor ;
Czeisler, Charles A. ;
Lockley, Steven W. ;
Jonsson, Eirikur ;
Launer, Lenore ;
Harris, Tamara ;
Gudnason, Vilmundur ;
Mucci, Lorelei A. ;
Markt, Sarah C. .
PROSTATE, 2021, 81 (08) :487-496
[4]   Serum and urine biomarkers for detecting clinically significant prostate cancer [J].
Becerra, Maria F. ;
Atluri, Venkatasai S. ;
Bhattu, Amit S. ;
Punnen, Sanoj .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (10) :686-690
[5]   Epidemiology and risk factors of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction [J].
Calogero, Aldo E. ;
Burgio, Giovanni ;
Condorelli, Rosita A. ;
Cannarella, Rossella ;
La Vignera, Sandro .
AGING MALE, 2019, 22 (01) :12-19
[6]   The New American Urological Association Benign Prostatic Hyperplasia Clinical Guidelines: 2019 Update [J].
Dornbier, Ryan ;
Pahouja, Gaurav ;
Branch, Jeffrey ;
McVary, Kevin T. .
CURRENT UROLOGY REPORTS, 2020, 21 (09)
[7]   Serum testosterone and prostate-specific antigen levels are major risk factors for prostatic volume increase among benign prostatic hyperplasia patients [J].
Duarsa, Gede Wirya Kusuma ;
Sari, Yudit Anastasia ;
Oka, Anak Agung Gde ;
Santosa, Kadek Budi ;
Yudiana, I. Wayan ;
Tirtayasa, Pande Made Wisnu ;
Pramana, Ida Bagus Putra ;
Kloping, Yudhistira Pradnyan .
ASIAN JOURNAL OF UROLOGY, 2021, 8 (03) :289-297
[8]  
Erfani S, 2022, Nuclear Medicine Review
[9]   Minimally invasive treatments for benign prostatic hyperplasia: a Cochrane network meta-analysis [J].
Franco, Juan Va ;
Jung, Jae Hung ;
Imamura, Mari ;
Borofsky, Michael ;
Omar, Muhammad Imran ;
Liquitay, Camila Micaela Escobar ;
Young, Shamar ;
Golzarian, Jafar ;
Veroniki, Areti Angeliki ;
Garegnani, Luis ;
Dahm, Philipp .
BJU INTERNATIONAL, 2022, 130 (02) :142-156
[10]   Differential diagnosis of uncommon prostate diseases: combining mpMRI and clinical information [J].
Han, Chao ;
Zhu, Lina ;
Liu, Xiang ;
Ma, Shuai ;
Liu, Yi ;
Wang, Xiaoying .
INSIGHTS INTO IMAGING, 2021, 12 (01)